REGISTERED COMPANY NUMBER:
|
REGISTERED CHARITY NUMBER:
|
Report of the Trustees and |
Unaudited Financial Statements for the Year Ended 30 June 2018 |
for |
Independent Fetal Anti-Convulsant Trust |
REGISTERED COMPANY NUMBER:
|
REGISTERED CHARITY NUMBER:
|
Report of the Trustees and |
Unaudited Financial Statements for the Year Ended 30 June 2018 |
for |
Independent Fetal Anti-Convulsant Trust |
Independent Fetal Anti-Convulsant Trust |
Contents of the Financial Statements |
for the Year Ended 30 June 2018 |
|
|
|
|
|
|
|
|
|
|
Page |
|
Report of the Trustees | 1 to 2 |
|
Independent Examiner's Report | 3 |
|
Statement of Financial Activities | 4 |
|
Balance Sheet | 5 |
|
Notes to the Financial Statements | 6 to 9 |
|
Independent Fetal Anti-Convulsant Trust |
Report of the Trustees |
for the Year Ended 30 June 2018 |
The trustees who are also directors of the charity for the purposes of the Companies Act 2006, present their report with |
the financial statements of the charity for the year ended 30 June 2018. The trustees have adopted the provisions of |
Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their |
accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) |
(effective 1 January 2015). |
|
Objectives and activities |
Objectives and aims |
The charity's main object is to relieve the needs of disabled persons whose disabilities were caused as a result of their |
mother taking an anti-convulsant drug during pregnancy to treat her condition in such ways as the trustees may from time |
to time decide. |
|
Significant activities |
The charity has carried out various activities to promote the objectives as follows: |
- House of Commons Debate on Valproate in Pregnancy |
- BBC Inside Out Documentary in February 2018 |
- Involvement in the re-writing of the Diagnostic Criteria for Fetal Valproate Spectrum Disorder |
- Involvement in the Independent Medicines and Medical Devices Review on Valproate |
- INFACT Conference held in House of Parliament |
|
Achievement and performance |
Following on from the extra pressure on the Government by INFACT through the European Review, INFACT were able |
to gather sufficient momentum in Parliament to hold a Back Bench Business Debate in the House of Commons |
Chambers in October on the topic of Valproate in pregnancy, which led to further meetings with the Department of |
Health and the Health Minister. |
|
Later that month INFACT received new research from China which questioned the use of Valproate in pregnancy and |
the effect that had transgenerationally, affecting the second and third generation. INFACT held a meeting with the BBC |
and the producer of Inside Out who commissioned a documentary to be made and which was shown in February. |
|
This is turn created a further meeting with the Department of Health who asked INFACT to respond to a Government |
remit and this was completed in May with the support of Specialists and Michael Mansfield QC. At the time the Health |
Minister Jeremy Hunt MP announced the review on medicines which included Valproate and was to be undertaken by |
Baroness Cumberlege, with the INFACT remit going to the review team. This caused many questions as it seemed the |
Government looked for time on the topic of a care plan and compensation to those who had been harmed by the drug. |
However, INFACT have been able to become involved with the Cumberlege Review attending meetings and offering |
advice. |
|
In March, INFACTs CEO was invited to join the panel of specialists surrounding Fetal Valproate Syndrome as a new |
Diagnostic Criteria was to be assessed. This will be completed in the Autumn with the criteria reaching into the autistic |
spectrum which affected so many of the children, and will be named the Fetal Valproate Spectrum Disorder. |
|
INFACT's proudest moment was in June where they held their first ever conference for Parents and Healthcare |
Professionals, this was held in the Houses of Parliament and was attended by the Medicines and Healthcare Products |
Regulatory Agency (MHRA), Baroness Cumberlege and her Review Team, their APPG Chair Norman Lamb MP and |
the Parliamentary Under Secretary for the health Secretary Lord James O'Shaughnessy. |
|
INFACT already have numerous ventures in the pipeline ready for the next 12 months of business with a constant flow |
of new families and data emerging, with around 1500 families on the database to date. |
|
Financial review |
The statement of financial activities shows a deficit of £4,314 and carried forward funds of £212. |
|
Donations and grants during the period were £2,215. |
|
Structure, governance and management |
Governing document |
The charity is controlled by its governing document, memorandum and articles of association, and consists a limited |
company, limited by guarantee, as defined by the Companies Act 2006. |
|
Independent Fetal Anti-Convulsant Trust |
Report of the Trustees |
for the Year Ended 30 June 2018 |
Reference and administrative details |
Registered Company number |
|
|
Registered Charity number |
|
|
Registered office |
|
|
|
|
|
|
|
Trustees |
|
Director |
|
Director |
|
Director |
|
Independent examiner |
RfM Fylde Limited |
|
Head Dyke Lane |
Pilling |
Preston |
Lancashire |
PR3 6SJ |
|
Bankers |
Natwest Bank plc |
Garstang Branch |
Market Place |
Garstang |
PR3 1ZA |
|
Approved by order of the board of
trustees
on
|
|
|
|
|
Independent Examiner's Report to the Trustees of |
Independent Fetal Anti-Convulsant Trust |
Independent examiner's report to the trustees of Independent Fetal Anti-Convulsant Trust ('the Company') |
I report to the charity trustees on my examination of the accounts of the Company for the year ended 30 June 2018 . |
|
Responsibilities and basis of report |
As the charity's trustees of the Company (and also its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act'). |
|
Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity's accounts as carried out under section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5) (b) of the 2011 Act. |
|
Independent examiner's statement |
I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe: |
|
1. | accounting records were not kept in respect of the Company as required by section 386 of the 2006 Act; or |
2. | the accounts do not accord with those records; or |
3. | the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination; or |
4. | the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities [applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)]. |
|
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached |
|
|
|
|
|
|
|
Alan Meikle |
FCA |
RfM Fylde Limited |
Summerdale |
Head Dyke Lane |
Pilling |
Preston |
Lancashire |
PR3 6SJ |
|
|
5 September 2018 |
Independent Fetal Anti-Convulsant Trust |
Statement of Financial Activities |
for the Year Ended 30 June 2018 |
2018 | 2017 |
|
Unrestricted
fund |
Total
funds |
Notes | £ | £ |
Income and endowments from |
Donations and legacies | 2 |
|
|
Total |
|
|
|
Expenditure on |
Charitable activities |
|
|
|
Net income/(expenditure) |
( |
) |
|
Reconciliation of funds |
|
Total funds brought forward |
|
( |
) |
Total funds carried forward |
|
4,526 |
Independent Fetal Anti-Convulsant Trust (Registered number: 09075755) |
Balance Sheet |
At 30 June 2018 |
2018 | 2017 |
|
Unrestricted
fund |
Total
funds |
Notes | £ | £ |
Fixed assets |
Tangible assets | 6 |
|
|
|
Current assets |
Cash at bank and in hand |
|
|
|
Creditors |
Amounts falling due within one year | 7 |
( |
) |
( |
) |
|
Net current assets/(liabilities) |
( |
) |
|
Total assets less current liabilities |
|
|
Net assets |
|
|
Funds | 9 |
Unrestricted funds | 212 | 4,526 |
Total funds |
|
4,526 |
The charitable company is entitled to exemption from audit under |
Section 477 of the Companies Act 2006 for the year ended 30 June 2018. |
|
The members have not required the company to obtain an audit of its financial statements for the year ended |
30 June 2018 in accordance with Section 476 of the Companies Act 2006. |
|
The trustees acknowledge their responsibilities for |
(a) |
ensuring that the charitable company keeps accounting records that comply with Sections 386 and 387 of the
Companies Act 2006 and |
(b) |
preparing financial statements which give a true and fair view of the state of affairs of the charitable company as
at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the charitable company. |
|
These financial statements have been prepared in accordance with the |
special provisions of Part 15 of the Companies Act 2006 relating to |
charitable small companies. |
|
The financial statements were approved by
the Board of
Trustees
on
|
|
|
|
|
|
Independent Fetal Anti-Convulsant Trust |
Notes to the Financial Statements |
for the Year Ended 30 June 2018 |
1. | Accounting policies |
|
Basis of preparing the financial statements |
The financial statements of the charitable company, which is a public benefit entity under FRS 102, have been |
prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement |
of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial |
Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2015)', |
Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of |
Ireland' and the Companies Act 2006. The financial statements have been prepared under the historical cost |
convention. |
|
Income |
All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it |
is probable that the income will be received and the amount can be measured reliably. |
|
Expenditure |
Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the |
charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and |
the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has |
been classified under headings that aggregate all cost related to the category. Where costs cannot be directly |
attributed to particular headings they have been allocated to activities on a basis consistent with the use of |
resources. |
|
Tangible fixed assets |
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful |
life. |
|
Fixtures and fittings |
|
|
Taxation |
The charity is exempt from corporation tax on its charitable activities. |
|
Fund accounting |
Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees. |
|
The total funds of the charity are unrestricted. |
|
2. | Donations and legacies |
|
2018 | 2017 |
£ | £ |
Donations |
|
|
Grants |
|
|
|
|
|
3. | Net income/(expenditure) |
|
Net income/(expenditure) is stated after charging/(crediting): |
|
2018 | 2017 |
£ | £ |
Depreciation - owned assets |
|
|
|
Independent Fetal Anti-Convulsant Trust |
Notes to the Financial Statements - continued |
for the Year Ended 30 June 2018 |
4. | Trustees' remuneration and benefits |
|
There were no trustees' remuneration or other benefits for the year ended 30 June 2018 nor for the year ended |
30 June 2017 . |
|
Trustees' expenses |
There were no trustees' expenses paid for the year ended 30 June 2018 nor for the year ended 30 June 2017 . |
|
5. | Comparatives for the statement of financial activities |
|
|
Unrestricted
fund |
£ |
Income and endowments from |
Donations and legacies |
|
Total |
|
|
Expenditure on |
Charitable activities |
|
|
Total |
|
Net income/(expenditure) |
|
Reconciliation of funds |
|
Total funds brought forward | (2,415 | ) |
Total funds carried forward | 4,526 |
|
6. | Tangible fixed assets |
|
Fixtures and
fittings |
£ |
Cost |
At 1 July 2017 and 30 June 2018 |
|
Depreciation |
At 1 July 2017 |
|
Charge for year |
|
At 30 June 2018 |
|
Net book value |
At 30 June 2018 |
|
At 30 June 2017 |
|
Independent Fetal Anti-Convulsant Trust |
Notes to the Financial Statements - continued |
for the Year Ended 30 June 2018 |
7. | Creditors: amounts falling due within one year |
|
2018 | 2017 |
£ | £ |
Other loans (see note 8) |
|
|
Accruals and deferred income |
|
|
|
|
|
8. | Loans |
|
An analysis of the maturity of loans is given below: |
|
2018 | 2017 |
£ | £ |
Amounts falling due within one year on demand: |
Directors' loans | 3,929 | 2,456 |
|
9. | Movement in funds |
|
|
At 1/7/17 |
Net movement
in funds |
At 30/6/18 |
£ | £ | £ |
Unrestricted funds |
General fund | 4,526 | (4,314 | ) | 212 |
|
TOTAL FUNDS |
|
(4,314 | ) | 212 |
|
Net movement in funds, included in the above are as follows: |
|
Incoming
resources |
Resources
expended |
Movement in
funds |
£ | £ | £ |
Unrestricted funds |
General fund | 2,214 | (6,528 | ) | (4,314 | ) |
|
TOTAL FUNDS |
|
( |
) | (4,314 | ) |
|
|
Comparatives for movement in funds |
|
At 1/7/16 |
Net movement
in funds |
At 30/6/17 |
£ | £ | £ |
|
Unrestricted Funds |
General fund | (2,415 | ) | 6,941 | 4,526 |
|
TOTAL FUNDS | (2,415 | ) | 6,941 | 4,526 |
Independent Fetal Anti-Convulsant Trust |
Notes to the Financial Statements - continued |
for the Year Ended 30 June 2018 |
9. | Movement in funds - continued |
|
Comparative net movement in funds, included in the above are as follows: |
|
Incoming
resources |
Resources
expended |
Movement in
funds |
£ | £ | £ |
Unrestricted funds |
General fund | 10,078 | (3,137 | ) | 6,941 |
|
TOTAL FUNDS | 10,078 | (3,137 | ) | 6,941 |
|
10. | Related party disclosures |
|
There were no related party transactions for the year ended 30 June 2018. |
|